Importantly, we solidly demonstrated that LRP10 has the lowest variability, the highest stability, and more consistency across two widely used techniques (RT-qPCR and microfluidic-based qPCR array); throughout all the analytical software employed, we showed highly stable expression levels in PPAT samples that are independent of the BMI and the presence PCa. The gene discussed is LRP10; the disease is posterior cortical atrophy.